Planning of tests is a key factor in a successful anti-doping program.

To set up the best possible anti-doping program there is a need of an in-depth analysis of the anti-doping requirements in the specific disciplines according to the doping substances anticipated to be used related to off-, pre- or in-season periods. This is called a Risk Assessment.

The International Standards for Testing (IST) created by WADA describes the need for a risk assessment in the process of planning doping controls. It states that a risk assessment should contain an evaluation of available doping analysis statistics, doping trends, training and competition seasons, the physical demands of each sport, and the performance enhancing effect of the various doping agents.

Clearidium has a significant experience in making Risk Assessments. But more importantly, Clearidium has implemented the Risk Assessment in various sports and thus assisted previously non-compliant Anti-Doping Organisations (ADO) to become compliant with WADA CODE.

The program contains:

1. Out-of-Competition (OOC) testing
2. In-Competition (IC) testing
3. Addressing the correct number of urine sample collections OOC and IC
a. To obtain a solid Steroid Profile
4. Addressing the correct number of blood sample collections OOC and IC
a. To obtain a valid blood profile; The Athlete Biological Passport (ABP)
b. To obtain the correct number of serum samples for immediate analyses and for storage and later re-analyses
At the end of the year, Clearidium produces an annual report showing that the requirements of the sport and discipline specific anti-doping test collections as per IST was met.


Clearidium A/S
Knabrostraede 20, 1
DK-1210 Copenhagen K

Phone: +45 3026 1611

Company No. 3255 3869